Xenetic Biosciences, Inc. (XBIO)
Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 73
+0.01
+0.5814%
After Hours
$
+0.17 +9.8266% 1. 90
4.03M Market Cap
- P/E Ratio
- Div Yield
45,548 Volume
0 Eps
$ 1.72
Previous Close 
Want to track XBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xenetic Biosciences, Inc. (XBIO) Statistics
Valuation metrics
Market Cap 4.03M
Enterprise value -2.44M
Trailing P/E (ttm) -1.45
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 1.24
Price/Book (mrq) 0.65
Enterprise Value/Revenue -0.75
Enterprise Value/EBITDA 0.99
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 18.86K
Average volume (90 days) 87.05K
Price summary
52-Week low 1.58
52-Week high 4.94
Beta -
50-Day moving average 2.63
200-Day moving average 2.99
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 15 May 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.76%
Operating margin -0.81%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.82
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.43%
Book value per share (mrq) 2.65
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
